Form 4 · Filed May 5, 2026, 09:29 PM UTC
VRTX/VERTEX PHARMACEUTICALS INC / MA
Schneider Jennifer — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 1, 2026 | A | other | 472 | $0 | — | 2,190 |
| May 1, 2026 | D | other | 796 | — | — | 1,394 |
| May 1, 2026 | A | other | 1,433 | $0 | — | 1,433 |
| May 1, 2026 | A | other | 796 | — | — | 796 |
Source: SEC EDGAR raw filing ↗ · Accession 0000875320-26-000189